Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | T3P-Y058-739 |
Trade Name | |
Synonyms | T3PY058739|T3P Y058739|T3PY 058739 |
Drug Descriptions |
T3P-Y058-739 is an attenuated bacterial strain carrying undisclosed type 1 Interferon and Toll-like receptor payloads, which potentially increases anti-tumor immune response and tumor cell killing (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C184738 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + T3P-Y058-739 | Pembrolizumab T3P-Y058-739 | 0 | 1 |
T3P-Y058-739 | T3P-Y058-739 | 0 | 1 |